Pfizer Inc (NYSE:PFE)
| 44.10 Delayed Data As of Sep 23 |  -0.47 / -1.05%Today’s Change | 40.94 Today|||52-Week Range 61.71 | -25.32% Year-to-Date |
Latest PFE News | Press Releases
Today’s Trading
| Previous close | 44.57 |
| Today’s open | 44.54 |
| Day’s range | 43.58 - 44.56 |
| Volume | 18,871,669 |
| Average volume (3 months) | 19,596,175 |
| Market cap | $247.4B |
Data as of 4:00pm ET, 09/23/2022
Growth & Valuation
| Earnings growth (last year) | +128.42% |
| Earnings growth (this year) | +47.13% |
| Earnings growth (next 5 years) | -10.50% |
| Revenue growth (last year) | +93.97% |
| P/E ratio | 8.6 |
| Price/Sales | 4.15 |
| Price/Book | 3.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +0.05 | +0.03% |
| MRKMerck | -0.72 | -0.82% |
| LLYEli Lilly and Co | +0.73 | +0.23% |
| NVONovo Nordisk | -0.37 | -0.38% |
Data as of 4:00pm ET, 09/23/2022
Financials
| Next reporting date | November 1, 2022 |
| EPS forecast (this quarter) | $1.50 |
| Annual revenue (last year) | $81.3B |
| Annual profit (last year) | $22.1B |
| Net profit margin | 27.57% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
